Cargando…
Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease
Behçet's disease (BD) involves multisystem vasculitis of unknown origin. Ocular manifestations of BD mostly include bilateral panuveitis and retinal vasculitis, which are very challenging to treat. Interferon alfa-2a (IFN) has been recently introduced for treating refractory Behçet uveitis, mai...
Autores principales: | Park, Ji-Youn, Chung, Yoo-Ri, Lee, Kihwang, Song, Ji Hun, Lee, Eun-So |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479849/ https://www.ncbi.nlm.nih.gov/pubmed/26069144 http://dx.doi.org/10.3349/ymj.2015.56.4.1158 |
Ejemplares similares
-
Interferon alpha-2a treatment for refractory Behcet uveitis in Korean patients
por: Lee, Ji Hwan, et al.
Publicado: (2018) -
Choroidal Thickness Indicates Subclinical Ocular and Systemic Inflammation in Eyes with Behçet Disease without Active Inflammation
por: Chung, Yoo-Ri, et al.
Publicado: (2018) -
Effectiveness and safety of interferon α2a as an add-on treatment for
refractory Behçet’s uveitis
por: Shi, Jing, et al.
Publicado: (2019) -
The use of interferon-alfa in Behçet's disease: review of the literature
por: Kötter, I, et al.
Publicado: (2003) -
Behçet's Uveitis
por: Tugal-Tutkun, Ilknur
Publicado: (2009)